PPARGC1A and neoplasm: Oxidative myofibers that are rich in PGC1α are more resistant than glycolytic ones to tumor-induced atrophy [15], but it is not known yet whether this resistance relies on a specific fiber type-related myokine that acts in an autocrine way.